Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Mar 2, 2010

Premium

Joel McComb is leaving his post as senior vice president and general manager of Illumina's Life Sciences business to become chief operating officer at Synthetic Genomics. McComb departed Illumina and took on the new position at SGI on March 1.

Before his time at Illumina, McComb was at General Electric, where he was president of Healthcare Life Sciences-Discovery Systems, and he served as president of GE Healthcare, Interventional Medicine. He also previously served as president and CEO of Innovadyne Technologies, a liquid-handling technology firm.

McComb's departure agreement from Illumina entitles him to a severance payment of nearly $260,000.


Ulf Jönsson has joined PharmaDiagnostics as non-executive director, the firm said this week.

Jönsson previously served as CEO of Cellectricon. He also was a co-founder and CEO of Biacore, now part of GE Healthcare.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.